Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis

NCT00420251 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Juvenile Idiopathic Arthritis
Still Disease, Juvenile-Onset

Interventions

DRUG: Genotropin

Sponsor

Ludwig-Maximilians - University of Munich

Collaborators

[object Object]